Susquehanna International Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-111,005
| Closed | -$2.24M | – | 6769 |
|
|
2021
Q3 | $2.24M | Sell |
111,005
-41,688
| -27% | -$840K | ﹤0.01% | 1844 |
|
|
2021
Q2 | $5.7M | Buy |
152,693
+108,476
| +245% | +$4.05M | ﹤0.01% | 1172 |
|
|
2021
Q1 | $1.13M | Sell |
44,217
-18,220
| -29% | -$466K | ﹤0.01% | 2831 |
|
|
2020
Q4 | $1.38M | Sell |
62,437
-131,270
| -68% | -$2.89M | ﹤0.01% | 2153 |
|
|
2020
Q3 | $3.49M | Buy |
193,707
+171,848
| +786% | +$3.09M | ﹤0.01% | 1033 |
|
|
2020
Q2 | $555K | Sell |
21,859
-4,300
| -16% | -$109K | ﹤0.01% | 2819 |
|
|
2020
Q1 | $481K | Buy |
+26,159
| New | +$481K | ﹤0.01% | 2920 |
|
|
2019
Q4 | – | Sell |
-26,862
| Closed | -$386K | – | 5110 |
|
|
2019
Q3 | $386K | Sell |
26,862
-9,318
| -26% | -$134K | ﹤0.01% | 3157 |
|
|
2019
Q2 | $570K | Buy |
+36,180
| New | +$570K | ﹤0.01% | 2782 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5104 |
|
|
2018
Q2 | – | Sell |
-86,291
| Closed | -$825K | – | 5066 |
|
|
2018
Q1 | $825K | Sell |
86,291
-13,083
| -13% | -$125K | ﹤0.01% | 1662 |
|
|
2017
Q4 | $897K | Buy |
+99,374
| New | +$897K | ﹤0.01% | 1870 |
|
|
2016
Q3 | – | Sell |
-11,130
| Closed | -$33K | – | 4245 |
|
|
2016
Q2 | $33K | Buy |
+11,130
| New | +$33K | ﹤0.01% | 3037 |
|